As of Mar 13, 2025, the Dynavax Technologies stock's PE ratio is 65.19. This takes into account the latest EPS of $0.21 and stock price of $13.69. The PE ratio marks a decrease of 35% from its last 4 quarters average of 99.7.
The PE ratio of Dynavax Technologies has averaged 41.67 over the last four years. The current P/E ratio of 65.19 is 56% higher than the historical average. Looking back at the last four years, DVAX's PE ratio peaked in the Mar 2024 quarter at 177.29, when the price was $12.41 and the EPS was $0.07. The lowest point was in the Sep 2022 quarter, when it reached 4.02 with a price of $10.44 and an EPS of $2.6.
Maximum annual decrease: -79.77% in 2022
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 60.81 | N/A | $12.77 | $0.21 |
2023 | N/A | N/A | $13.98 | -$0.05 |
2022 | 4.59 | -79.77% | $10.64 | $2.32 |
2021 | 22.69 | N/A | $14.07 | $0.62 |
2020 | N/A | N/A | $4.45 | -$0.75 |
2019 | N/A | N/A | $5.72 | -$2.16 |
2018 | N/A | N/A | $9.15 | -$2.55 |
2017 | N/A | N/A | $18.7 | -$1.81 |
2016 | N/A | N/A | $3.95 | -$2.92 |
2015 | N/A | N/A | $24.16 | -$3.25 |
2014 | N/A | N/A | $16.86 | -$3.45 |
2013 | N/A | N/A | $19.6 | -$3.83 |
2012 | N/A | N/A | $28.5 | -$4.1 |
2011 | N/A | N/A | $33.2 | -$3.9 |
2010 | N/A | N/A | $32 | -$6.9 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 60.81 | -18.12% | $12.77 | $0.21 |
Sep 2024 | 74.27 | -14.02% | $11.14 | $0.15 |
Jun 2024 | 86.38 | -51.28% | $11.23 | $0.13 |
Mar 2024 | 177.29 | N/A | $12.41 | $0.07 |
Dec 2023 | N/A | N/A | $13.98 | -$0.05 |
Sep 2023 | 30.77 | 107.21% | $14.77 | $0.48 |
Jun 2023 | 14.85 | 181.78% | $12.92 | $0.87 |
Mar 2023 | 5.27 | 14.81% | $9.81 | $1.86 |
Dec 2022 | 4.59 | 14.18% | $10.64 | $2.32 |
Sep 2022 | 4.02 | -40.62% | $10.44 | $2.6 |
Jun 2022 | 6.77 | -45.05% | $12.59 | $1.86 |
Mar 2022 | 12.32 | -45.7% | $10.84 | $0.88 |
Dec 2021 | 22.69 | N/A | $14.07 | $0.62 |
Sep 2021 | N/A | N/A | $19.21 | -$0.33 |
Jun 2021 | N/A | N/A | $9.85 | -$0.05 |
Currently, DVAX's PE ratio is higher than its 3, 5 and 10-year averages.
DVAX's PE ratio stands lower than its peer stock GILD, but it is higher than MRK's and AZN's. Dynavax Technologies is currently trading at a higher PE ratio (65.19) than its peers average of 23.85.
Stock name | PE ratio | Market cap |
---|---|---|
BIIB Biogen Inc | 12.48 | $20.48B |
MRK Merck & Co Inc | 13.96 | $238.41B |
PFE Pfizer Inc | 18.12 | $145.85B |
AZN Astrazeneca plc | 34.13 | $240.24B |
AMGN Amgen Inc | 41.1 | $168.25B |
DVAX Dynavax Technologies Corp | 66.26 | $1.73B |
GILD Gilead Sciences Inc | 293.03 | $138.67B |
AGEN Agenus Inc | N/A | $42.81M |
TEVA Teva Pharmaceutical Industries Ltd | N/A | $18.66B |
The price to earnings ratio for DVAX stock as of Mar 13, 2025, stands at 65.19.
As an average over the last 3 years, DVAX stock has a PE ratio of 43.39.
As an average over the last 5 years, DVAX stock has a PE ratio of 41.67.
The highest quarterly PE ratio in the last four years has been 177.29 and it was in the Mar 2024 quarter.
DVAX's price to earnings ratio is currently 56% above its 4-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Mar 13, 2025), Dynavax Technologies's share price is $13.69. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.21. Therefore, Dynavax Technologies's PE ratio for today is 65.19. PE RATIO(65.19) = STOCK PRICE($13.69) / TTM EPS($0.21)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.